These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34335761)

  • 21. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database.
    Li W; Zhang M; Fu S; Hao X; Song L; Wang J; Liu B; Xu S
    Transl Cancer Res; 2022 Aug; 11(8):2783-2794. PubMed ID: 36093529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis.
    Wang X; Chen D; Wen J; Mao Y; Zhu X; Fan M; Chen Y
    Ann Transl Med; 2021 Sep; 9(18):1430. PubMed ID: 34733982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy?
    Wang Y; Guo S; Zhang J; Meng XY; Zheng ZC; Zhao Y
    Scand J Gastroenterol; 2020 Feb; 55(2):193-201. PubMed ID: 31976783
    [No Abstract]   [Full Text] [Related]  

  • 26. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of prognostic nomogram for high-grade parotid gland mucoepidermoid carcinoma based on the SEER database.
    Wu Y; Wu S; Li X
    Ear Nose Throat J; 2022 Apr; ():1455613221089994. PubMed ID: 35418268
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database.
    Shi S; Wang H; Liu X; Xiao J
    Transl Cancer Res; 2021 Dec; 10(12):5191-5203. PubMed ID: 35116369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.
    Liao Y; Wang X; Zhong P; Yin G; Fan X; Huang C
    Oncol Lett; 2019 Dec; 18(6):5905-5916. PubMed ID: 31788064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 31. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 32. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
    Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
    Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
    Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
    Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival value of primary tumour resection for stage IV non-small-cell lung cancer: A population-based study of 6466 patients.
    Xu J; Fan L; Yu H; Lu D; Peng W; Sun G
    Clin Respir J; 2020 Aug; 14(8):763-771. PubMed ID: 32301272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy improves the prognosis of early stage resectable pulmonary large cell carcinoma: analysis of SEER data.
    Hu X; Tai Q; Su B; Zhang L
    Ann Palliat Med; 2020 Mar; 9(2):199-206. PubMed ID: 32156139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data.
    Ye X; Liu Y; Yang J; Wang Y; Cui X; Xie H; Song L; Ding Z; Zhai R; Han Y; Yang L; Zhang H
    Eur J Surg Oncol; 2022 Sep; 48(9):1954-1963. PubMed ID: 35379544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
    Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalizing prognostic prediction in early-onset Colorectal Cancer.
    Liu J; Liu Z; Li J; Tian S; Dong W
    J Cancer; 2020; 11(22):6727-6736. PubMed ID: 33046995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram application to predict overall and cancer-specific survival in osteosarcoma.
    Zheng W; Huang Y; Chen H; Wang N; Xiao W; Liang Y; Jiang X; Su W; Wen S
    Cancer Manag Res; 2018; 10():5439-5450. PubMed ID: 30519092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.